PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Interdisciplinary Department of Medicine - Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari \'Aldo Moro\', Bari, Italy.\', \'Outpatients Clinic of Endocrinology and Metabolic Disease, Conversano Hospital, Bari, Italy.\', \'Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, Bari, Italy.\', \'Unit of Endocrinology, Metabolic Disease & Clinical Nutrition, Hospital \'A. Perrino\', Brindisi, Italy.\', \'Departmentof Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/andr.12836
?:doi
?:hasPublicationType
?:journal
  • Andrology
is ?:pmid of
?:pmid
?:pmid
  • 32524732
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.154
?:rankingScore_hIndex
  • 24
is ?:relation_isRelatedTo_publication of
?:title
  • Worse progression of COVID-19 in men: Is testosterone a key factor?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all